Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC

Authors: Sharma, Rohini, Pillai, Anjana, Marron, Thomas Urban, Fessas, Petros, Saeed, Anwaar, Jun, Tomi, Dharmapuri, Sirish, Szafron, David, Naqash, Abdul Rafeh, Gampa, Anuhya, Wang, Yinghong, Khan, Uqba, Muzaffar, Mahvish, Lee, Chieh‐Ju, Lee, Pei‐Chang, Bulumulle, Anushi, Paul, Sonal, Bettinger, Dominic, Hildebrand, Hannah, Yehia, Mohammed, Pressiani, Tiziana, Kaseb, Ahmed, Huang, Yi‐Hsiang, Ang, Celina, Kudo, Masatoshi, Nishida, Naoshi, Personeni, Nicola, Rimassa, Lorenza, Pinato, David James

Source: Hepatology communications. 6(7):1776-1785

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100154052157.0x000001&indx=1&recIds=ETOCvdc_100154052157.0x000001

Use of pathological response versus RECIST assessment in predicting relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma.

Authors: D'Alessio, Antonio, Lombardi, Pasquale, Stefanini, Bernardo, Blanter, Julia, Crowley, Fionnuala, Shu, Daniel, Yip, Vincent, Slater, Sarah, Pai, Madhava, Goldin, Robert D., Ward, Stephen, Fiel, M. Isabel, Su, Yung-Yeh, Baretti, Marina, Anders, Robert A., Yarchoan, Mark, Hsu, Chiun, Marron, Thomas Urban, Sharma, Rohini, Pinato, David James

Source: Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, p633-633, 132p

Qualification of major pathological response as a surrogate endpoint for relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma.

Authors: D'Alessio, Antonio, Stefanini, Bernardo, Blanter, Julia, Adegbite, Benjamin, Fulgenzi, Claudia A.M., Celsa, Ciro, Manfredi, Giulia F, Pai, Madhava, Goldin, Robert D., Shu, Daniel, Su, Yung-Yeh, Baretti, Marina, Anders, Robert A., Yarchoan, Mark, Hsu, Chiun, Marron, Thomas Urban, Pinato, David James

Source: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p506-506, 151p

Efficacy of immune checkpoint inhibitors in patients with HIV-associated unresectable HCC (uHCC): Propensity-score matched analyses from two international consortia.

Authors: Fulgenzi, Claudia A.M., El Zarif, Talal, Nassar, Amin, Adib, Elio, Bellmunt, Joaquim, Marron, Thomas Urban, Lorentsen, Michael, McKay, Rana R., Baena, Javier, Ang, Celina, Rimassa, Lorenza, Kudo, Masatoshi, Parisi, Alessandro, Saeed, Anwaar, Lee, Pei-Chang, Parikh, Neehar, Pinter, Matthias, Cortellini, Alessio, Naqash, Abdul Rafeh, Pinato, David James

Source: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p442-442, 151p

Financial toxicity in patients with advanced solid malignancies participating in early-phase clinical trials.

Authors: Blanter, Julia, Werner, Michael, Kier, Melanie Wain, Hapanowicz, Olivia, Itani, Muhieddine, Ahmad, Maham, DeMerchant, Mandy, Eder, Joseph Paul, Galsky, Matt D., Hammad, Ashley, King, Paula, Lachowicz, Michael, Lucas, Natalie, Marron, Thomas Urban, Shelton, Gary, Wu, Kathy, Xu, Suzanne, LoRusso, Patricia, Hofstatter, Erin Wysong, Doroshow, Deborah Blythe

Source: Journal of clinical oncology. 40(28 suppl):267-267

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100179131447.0x000001&indx=1&recIds=ETOCvdc_100179131447.0x000001

Treatment-related toxicity and improved outcomes with immune checkpoint inhibitors in patients with hepatocellular carcinoma.

Authors: Cortellini, Alessio, Marron, Thomas Urban, Mishra-Kalyani, Pallavi Shruti, Gong, Yutao, Saeed, Anwaar, Jun, Tomi, Dharmapuri, Sirish, Naqash, Abdul Rafeh, Khan, Uqba, Kaseb, Ahmed Omar, Huang, Yi-Hsiang, Ang, Celina, Schneider, Julie A., Pillai, Anjana, Rimassa, Lorenza, Pazdur, Richard, Theoret, Marc Robert, Lemery, Steven, Pelosof, Lorraine Cheryl, Pinato, David James

Source: Journal of clinical oncology. 39(15 suppl):4085-4085

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173197409.0x000001&indx=1&recIds=ETOCvdc_100173197409.0x000001

Personalized DNA neoantigen vaccine in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma.

Authors: Yarchoan, Mark, Gane, Edward, Marron, Thomas Urban, Rochestie, Sarah, Cooch, Neil, Peters, Joann, Csiki, Ildiko, Perales-Puchalt, Alfredo, Sardesai, Niranjan

Source: Journal of clinical oncology. 39(15 suppl):TPS2680-TPS2680

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173187787.0x000001&indx=1&recIds=ETOCvdc_100173187787.0x000001

Nivolumab/ipilimumab primed immunotransplant in post-CAR-T and post-ASCT DLBCL.

Authors: Fitzgerald, Bailey Gleason, Marron, Thomas Urban, Ostrowski, Dana, Shulman, Jonah, Kalac, Matko, Marshall, Netonia, Brody, Joshua

Source: Journal of clinical oncology. 39(15 suppl):2593-2593

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173186470.0x000001&indx=1&recIds=ETOCvdc_100173186470.0x000001

Tracking MRD and neoantigen targets using a tumor-informed liquid biopsy platform in HCC patients treated with personalized cancer vaccine and pembrolizumab.

Authors: Yan, Jian, Perales, Renzo, Bartha, Gabor, Northcott, Josette, Chen, Richard, Lyle, John, Norton, Dan, Abbott, Charles, Li, Bailiang, Boyle, Sean Michael, Perales-Puchalt, Alfredo, Cooch, Neil, Gane, Edward, Yarchoan, Mark, Marron, Thomas Urban, Rochestie, Sarah, Peters, Joann, Csiki, Ildiko, Sardesai, Niranjan Y.

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe15062-e15062, 1p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.